Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells.

PubWeight™: 1.85‹?› | Rank: Top 3%

🔗 View Article (PMID 18041019)

Published in J Med Virol on January 01, 2008

Authors

Zhihua Kou1, Matthew Quinn, Huiyuan Chen, W W Shanaka I Rodrigo, Robert C Rose, Jacob J Schlesinger, Xia Jin

Author Affiliations

1: Department of Medicine, Infectious Diseases Division, University of Rochester, Rochester, New York 14642, USA.

Articles citing this

Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev (2009) 3.61

Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease. Cell Host Microbe (2010) 3.33

Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections. J Virol (2010) 3.10

DENV inhibits type I IFN production in infected cells by cleaving human STING. PLoS Pathog (2012) 1.80

STAT2 mediates innate immunity to Dengue virus in the absence of STAT1 via the type I interferon receptor. PLoS Pathog (2011) 1.54

Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever. Virology (2008) 1.54

Broad antiviral activity of carbohydrate-binding agents against the four serotypes of dengue virus in monocyte-derived dendritic cells. PLoS One (2011) 1.52

Dengue virus inhibits the production of type I interferon in primary human dendritic cells. J Virol (2010) 1.42

A shorter time interval between first and second dengue infections is associated with protection from clinical illness in a school-based cohort in Thailand. J Infect Dis (2013) 1.33

Innate immunity evasion by Dengue virus. Viruses (2012) 1.29

Ligation of Fc gamma receptor IIB inhibits antibody-dependent enhancement of dengue virus infection. Proc Natl Acad Sci U S A (2011) 1.24

Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection. J Virol (2010) 1.23

Dengue virus co-opts UBR4 to degrade STAT2 and antagonize type I interferon signaling. PLoS Pathog (2013) 1.20

Primary human splenic macrophages, but not T or B cells, are the principal target cells for dengue virus infection in vitro. J Virol (2007) 1.20

Timing of CD8+ T cell responses in relation to commencement of capillary leakage in children with dengue. J Immunol (2010) 1.20

Cellular and cytokine correlates of severe dengue infection. PLoS One (2012) 1.08

Mouse models to study dengue virus immunology and pathogenesis. Front Immunol (2014) 1.06

Fusion loop peptide of the West Nile virus envelope protein is essential for pathogenesis and is recognized by a therapeutic cross-reactive human monoclonal antibody. J Immunol (2009) 1.05

Inhibition of dengue and chikungunya virus infections by RIG-I-mediated type I interferon-independent stimulation of the innate antiviral response. J Virol (2014) 1.03

Dendritic cells in dengue virus infection: targets of virus replication and mediators of immunity. Front Immunol (2014) 1.01

Identification of new protein interactions between dengue fever virus and its hosts, human and mosquito. PLoS One (2013) 1.01

Molecular mechanisms involved in the early steps of flavivirus cell entry. Microbes Infect (2010) 1.00

Suppression of virus specific immune responses by IL-10 in acute dengue infection. PLoS Negl Trop Dis (2013) 0.99

Dengue virus tropism in humanized mice recapitulates human dengue fever. PLoS One (2011) 0.99

CD8+ T cells prevent antigen-induced antibody-dependent enhancement of dengue disease in mice. J Immunol (2014) 0.98

Dengue virus neutralization is modulated by IgG antibody subclass and Fcgamma receptor subtype. Virology (2009) 0.97

Lectin switching during dengue virus infection. J Infect Dis (2011) 0.95

An adjuvanted, tetravalent dengue virus purified inactivated vaccine candidate induces long-lasting and protective antibody responses against dengue challenge in rhesus macaques. Am J Trop Med Hyg (2015) 0.93

Both viremia and cytokine levels associate with the lack of severe disease in secondary dengue 1 infection among adult Chinese patients. PLoS One (2010) 0.92

Susceptibility and response of human blood monocyte subsets to primary dengue virus infection. PLoS One (2012) 0.91

Dengue virus infection-enhancing activity in serum samples with neutralizing activity as determined by using FcγR-expressing cells. PLoS Negl Trop Dis (2012) 0.90

Difference between the abilities of human Fcgamma receptor-expressing CV-1 cells to neutralize American and Asian genotypes of dengue virus 2. Clin Vaccine Immunol (2008) 0.88

Discrepancy in dengue virus neutralizing antibody titers between plaque reduction neutralizing tests with Fcgamma receptor (FcgammaR)-negative and FcgammaR-expressing BHK-21 cells. Clin Vaccine Immunol (2009) 0.86

Dengue virus entry as target for antiviral therapy. J Trop Med (2012) 0.86

Foot-and-mouth disease virus exhibits an altered tropism in the presence of specific immunoglobulins, enabling productive infection and killing of dendritic cells. J Virol (2010) 0.85

Maturation of dengue virus nonstructural protein 4B in monocytes enhances production of dengue hemorrhagic fever-associated chemokines and cytokines. Virology (2011) 0.85

Spleen Tyrosine Kinase (Syk) Mediates IL-1β Induction by Primary Human Monocytes during Antibody-enhanced Dengue Virus Infection. J Biol Chem (2015) 0.84

Immunopathogenesis Versus Protection in Dengue Virus Infections. Curr Trop Med Rep (2014) 0.83

Liposome-mediated delivery of iminosugars enhances efficacy against dengue virus in vivo. Antimicrob Agents Chemother (2012) 0.82

Dengue virus neutralization in cells expressing Fc gamma receptors. PLoS One (2013) 0.82

Suppression of Drug Resistance in Dengue Virus. MBio (2015) 0.81

Within-host viral dynamics of dengue serotype 1 infection. J R Soc Interface (2014) 0.80

Mosquito Saliva Increases Endothelial Permeability in the Skin, Immune Cell Migration, and Dengue Pathogenesis during Antibody-Dependent Enhancement. PLoS Pathog (2016) 0.80

Elucidating the role of T cells in protection against and pathogenesis of dengue virus infections. Future Microbiol (2014) 0.78

Vascular leakage in dengue hemorrhagic Fever is associated with dengue infected monocytes, monocyte activation/exhaustion, and cytokines production. Int J Vasc Med (2015) 0.78

Utility of humanized BLT mice for analysis of dengue virus infection and antiviral drug testing. J Virol (2013) 0.78

Oligomeric procyanidins stimulate innate antiviral immunity in dengue virus infected human PBMCs. Antiviral Res (2011) 0.78

Japanese encephalitis vaccine-facilitated dengue virus infection-enhancement antibody in adults. BMC Infect Dis (2016) 0.77

Monocytes and B cells support active replication of Chandipura virus. BMC Infect Dis (2016) 0.77

A novel reporter system for neutralizing and enhancing antibody assay against dengue virus. BMC Microbiol (2014) 0.77

Study of viral pathogenesis in humanized mice. Curr Opin Virol (2015) 0.76

Dengue virus induces mitochondrial elongation through impairment of Drp1-triggered mitochondrial fission. Virology (2016) 0.76

Dengue Virus Directly Stimulates Polyclonal B Cell Activation. PLoS One (2015) 0.76

The Cellular Bases of Antibody Responses during Dengue Virus Infection. Front Immunol (2016) 0.75

In silico transcriptional regulation and functional analysis of dengue shock syndrome associated SNPs in PLCE1 and MICB genes. Funct Integr Genomics (2016) 0.75

Source and Purity of Dengue-Viral Preparations Impact Requirement for Enhancing Antibody to Induce Elevated IL-1β Secretion: A Primary Human Monocyte Model. PLoS One (2015) 0.75

The Role of Heterotypic DENV-specific CD8(+)T Lymphocytes in an Immunocompetent Mouse Model of Secondary Dengue Virus Infection. EBioMedicine (2017) 0.75

Vitamin D-Regulated MicroRNAs: Are They Protective Factors against Dengue Virus Infection? Adv Virol (2016) 0.75

Suppression of chikungunya virus replication and differential innate responses of human peripheral blood mononuclear cells during co-infection with dengue virus. PLoS Negl Trop Dis (2017) 0.75

Articles by these authors

Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor. J Immunol (2005) 4.18

Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes. J Virol (2007) 2.89

Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003-11): a national observational cohort study. Lancet (2012) 2.41

Interleukin-6-driven progranulin expression increases cholangiocarcinoma growth by an Akt-dependent mechanism. Gut (2011) 1.91

Simulation and prediction of the adaptive immune response to influenza A virus infection. J Virol (2009) 1.76

APOBEC3G/CEM15 (hA3G) mRNA levels associate inversely with human immunodeficiency virus viremia. J Virol (2005) 1.63

Discontinuation of antiretroviral therapy commenced early during the course of human immunodeficiency virus type 1 infection, with or without adjunctive vaccination. J Infect Dis (2002) 1.45

Differential enhancement of dengue virus immune complex infectivity mediated by signaling-competent and signaling-incompetent human Fcgamma RIA (CD64) or FcgammaRIIA (CD32). J Virol (2006) 1.34

Prevalence of human papillomavirus genotypes and related abnormalities of cervical cytological results among HIV-1-infected women in Rochester, New York. J Infect Dis (2006) 1.32

Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS). J Neuroimmunol (2004) 1.27

Safety and immunogenicity of an HIV-1 gag DNA vaccine with or without IL-12 and/or IL-15 plasmid cytokine adjuvant in healthy, HIV-1 uninfected adults. PLoS One (2012) 1.25

Sexual behavior and risks for HIV infection and transmission among male injecting drug users in Yunnan, China. Int J Infect Dis (2008) 1.24

Mobility, risk behavior and HIV/STI rates among female sex workers in Kaiyuan City, Yunnan Province, China. BMC Infect Dis (2010) 1.23

Primary human splenic macrophages, but not T or B cells, are the principal target cells for dengue virus infection in vitro. J Virol (2007) 1.20

Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China. Carcinogenesis (2004) 1.18

Nuclear import strategies of high risk HPV16 L1 major capsid protein. J Biol Chem (2002) 1.17

Arenavirus nucleoprotein targets interferon regulatory factor-activating kinase IKKε. J Virol (2012) 1.15

The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma. Carcinogenesis (2005) 1.12

A phase I trial of preventive HIV vaccination with heterologous poxviral-vectors containing matching HIV-1 inserts in healthy HIV-uninfected subjects. Vaccine (2011) 1.11

Evaluation of a multiple-cycle, recombinant virus, growth competition assay that uses flow cytometry to measure replication efficiency of human immunodeficiency virus type 1 in cell culture. J Clin Microbiol (2006) 1.10

An automated Dengue virus microneutralization plaque assay performed in human Fc{gamma} receptor-expressing CV-1 cells. Am J Trop Med Hyg (2009) 1.10

Oral immunogenicity of human papillomavirus-like particles expressed in potato. J Virol (2003) 1.09

Yellow fever virus/dengue-2 virus and yellow fever virus/dengue-4 virus chimeras: biological characterization, immunogenicity, and protection against dengue encephalitis in the mouse model. J Virol (2003) 1.05

Accurate and reliable quantification of total microalgal fuel potential as fatty acid methyl esters by in situ transesterification. Anal Bioanal Chem (2012) 1.05

Precise determination of time to reach viral load set point after acute HIV-1 infection. J Acquir Immune Defic Syndr (2012) 1.05

Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China. Gynecol Oncol (2005) 1.02

9G4 autoreactivity is increased in HIV-infected patients and correlates with HIV broadly neutralizing serum activity. PLoS One (2012) 1.02

The functional SNP in the matrix metalloproteinase-3 promoter modifies susceptibility and lymphatic metastasis in esophageal squamous cell carcinoma but not in gastric cardiac adenocarcinoma. Carcinogenesis (2004) 1.01

Alteration of bile acid metabolism in the rat induced by chronic ethanol consumption. FASEB J (2013) 1.00

HIV incidence and associated risk factors among female sex workers in a high HIV-prevalence area of China. Sex Transm Dis (2012) 0.99

Chronic ethanol consumption alters mammalian gastrointestinal content metabolites. J Proteome Res (2013) 0.97

Fighting Ebola with ZMapp: spotlight on plant-made antibody. Sci China Life Sci (2014) 0.97

Dengue virus neutralization is modulated by IgG antibody subclass and Fcgamma receptor subtype. Virology (2009) 0.97

Human antibodies against dengue enhance dengue viral infectivity without suppressing type I interferon secretion in primary human monocytes. Virology (2010) 0.96

The associations between psychosocial stress and the frequency of illness, and innate and adaptive immune function in children. Brain Behav Immun (2008) 0.96

Cyclooxygenase-2 inhibition attenuates antibody responses against human papillomavirus-like particles. J Immunol (2006) 0.96

Statistical determination of threshold for cellular division in the CFSE-labeling assay. J Immunol Methods (2006) 0.96

The L1 major capsid protein of human papillomavirus type 11 interacts with Kap beta2 and Kap beta3 nuclear import receptors. Virology (2003) 0.95

Evaluation of multitype mathematical models for CFSE-labeling experiment data. Bull Math Biol (2011) 0.95

Unique impacts of HBV co-infection on clinical and laboratory findings in a recent dengue outbreak in China. Am J Trop Med Hyg (2008) 0.94

Systemic immune system alterations in early stages of Alzheimer's disease. J Neuroimmunol (2013) 0.94

A tetravalent recombinant dengue domain III protein vaccine stimulates neutralizing and enhancing antibodies in mice. Vaccine (2010) 0.93

Murine cytomegalovirus abortively infects human dendritic cells, leading to expression and presentation of virally vectored genes. J Virol (2003) 0.92

Both viremia and cytokine levels associate with the lack of severe disease in secondary dengue 1 infection among adult Chinese patients. PLoS One (2010) 0.92

Cholangiocarcinoma pathogenesis: Role of the tumor microenvironment. Transl Gastrointest Cancer (2012) 0.91

Application of the BED capture enzyme immunoassay for HIV incidence estimation among female sex workers in Kaiyuan City, China, 2006-2007. Int J Infect Dis (2010) 0.88

Antigenic presentation of heterologous epitopes engineered into the outer surface-exposed helix 4 loop region of human papillomavirus L1 capsomeres. Virol J (2009) 0.88

Single-cell cytokine analysis allows detection of cervical T-cell responses against human papillomavirus type 16 L1 in women infected with genital HPV. J Med Virol (2002) 0.87

No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma. Lung Cancer (2005) 0.86

HIV-specific cytotoxic cell frequencies measured directly ex vivo by the Lysispot assay can be higher or lower than the frequencies of IFN-gamma-secreting cells: anti-HIV cytotoxicity is not generally impaired relative to other chronic virus responses. J Immunol (2006) 0.86

Association of family stress with natural killer cell activity and the frequency of illnesses in children. Arch Pediatr Adolesc Med (2007) 0.84

Primary human endothelial cells support direct but not antibody-dependent enhancement of dengue viral infection. J Med Virol (2009) 0.84

Differential effects of grape powder and its extract on glucose tolerance and chronic inflammation in high-fat-fed obese mice. J Agric Food Chem (2012) 0.84

Fc receptor-mediated, antibody-dependent enhancement of bacteriophage lambda-mediated gene transfer in mammalian cells. Virology (2008) 0.84

Sept6 is required for ciliogenesis in Kupffer's vesicle, the pronephros, and the neural tube during early embryonic development. Mol Cell Biol (2014) 0.84

Interleukin-2 reconstitutes defective human immunodeficiency virus (HIV), and cytomegalovirus (CMV) specific CD8+ T cell proliferation in HIV infection. J Med Virol (2006) 0.83

A humanized IgG but not IgM antibody is effective in prophylaxis and therapy of yellow fever infection in an AG129/17D-204 peripheral challenge mouse model. Antiviral Res (2012) 0.83

Evaluation of CD8+ T-cell and antibody responses following transient increased viraemia in rhesus macaques infected with live, attenuated simian immunodeficiency virus. J Gen Virol (2005) 0.83

Chronic inhibition of cyclooxygenase-2 attenuates antibody responses against vaccinia infection. Vaccine (2009) 0.83

Epoxide hydrolase Tyr113His polymorphism is not associated with susceptibility to esophageal squamous cell carcinoma in population of North China. World J Gastroenterol (2003) 0.83

Use of TSHβ:EGFP transgenic zebrafish as a rapid in vivo model for assessing thyroid-disrupting chemicals. Toxicol Appl Pharmacol (2012) 0.82

A metabolomics-based strategy for the quality control of traditional chinese medicine: shengmai injection as a case study. Evid Based Complement Alternat Med (2013) 0.82

Human papillomavirus-like particles mediate functional delivery of plasmid DNA to antigen presenting cells in vivo. Vaccine (2007) 0.82

Monoamine oxidase A expression is suppressed in human cholangiocarcinoma via coordinated epigenetic and IL-6-driven events. Lab Invest (2012) 0.82

The novel growth factor, progranulin, stimulates mouse cholangiocyte proliferation via sirtuin-1-mediated inactivation of FOXO1. Am J Physiol Gastrointest Liver Physiol (2012) 0.81

A new signal-on photoelectrochemical biosensor based on a graphene/quantum-dot nanocomposite amplified by the dual-quenched effect of bipyridinium relay and AuNPs. Chemistry (2012) 0.81

Salmonella typhi Ty21a bacterial ghost vector augments HIV-1 gp140 DNA vaccine-induced peripheral and mucosal antibody responses via TLR4 pathway. Vaccine (2012) 0.81

Recurrent exercise-induced acute kidney injury by idiopathic renal hypouricemia with a novel mutation in the SLC2A9 gene and literature review. BMC Pediatr (2014) 0.81

Patient-centered medical home cyberinfrastructure current and future landscape. Am J Prev Med (2011) 0.81

A human papillomavirus type 16 vaccine by oral delivery of L1 protein. Virus Res (2005) 0.80

The characteristics and risk factors for HIV infection among Beijing drug users in different settings. Drug Alcohol Depend (2010) 0.80

[Association of single nucleotide polymorphism in matrix metalloproteinases promoter with susceptibility to ovarian cancer]. Zhonghua Fu Chan Ke Za Zhi (2005) 0.79

Familial steroid-sensitive idiopathic nephrotic syndrome: seven cases from three families in China. Clinics (Sao Paulo) (2013) 0.79

A new photoelectrochemical aptasensor for the detection of thrombin based on functionalized graphene and CdSe nanoparticles multilayers. Chem Commun (Camb) (2011) 0.79

Serum suPAR levels help differentiate steroid resistance from steroid-sensitive nephrotic syndrome in children. Pediatr Nephrol (2014) 0.79

The roles of follistatin 1 in regulation of zebrafish fecundity and sexual differentiation. Biol Reprod (2012) 0.78

Effects of L1-ORF2 fragments on green fluorescent protein gene expression. Genet Mol Biol (2009) 0.78

Separation and quantification of microalgal carbohydrates. J Chromatogr A (2012) 0.78

Aptamer based photoelectrochemical cytosensor with layer-by-layer assembly of CdSe semiconductor nanoparticles as photoelectrochemically active species. Biosens Bioelectron (2011) 0.78